Click here to get full coverage on Virpax Pharmaceuticals to be delisted from Nasdaq - Investing.com

Virpax Pharmaceuticals to be delisted from Nasdaq  Investing.com

Virpax Pharmaceuticals to be delisted from Nasdaq - Investing.com

Click here to get full coverage on Virpax Pharmaceuticals stock plummets on Nasdaq delisting news - Investing.com

Virpax Pharmaceuticals stock plummets on Nasdaq delisting news  Investing.com

Virpax Pharmaceuticals stock plummets on Nasdaq delisting news - Investing.com

Click here to get full coverage on VRPX - Virpax Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

VRPX - Virpax Pharmaceuticals Inc Latest Stock News & Market Updates  Stock Titan

VRPX - Virpax Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Virpax: A Promising Stock In A Sickly Biotech Market - Forbes

Virpax: A Promising Stock In A Sickly Biotech Market  Forbes

Virpax: A Promising Stock In A Sickly Biotech Market - Forbes

Click here to get full coverage on VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024 - InvestorPlace

VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024  InvestorPlace

VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024 - InvestorPlace

Click here to get full coverage on Virpax Pharmaceuticals enacts 1-for-25 reverse stock split - Investing.com

Virpax Pharmaceuticals enacts 1-for-25 reverse stock split  Investing.com

Virpax Pharmaceuticals enacts 1-for-25 reverse stock split - Investing.com

Click here to get full coverage on Virpax Pharmaceuticals Raises $5M in Public Offering to Advance Pain Management Drug - Stock Titan

Virpax Pharmaceuticals Raises $5M in Public Offering to Advance Pain Management Drug  Stock Titan

Virpax Pharmaceuticals Raises $5M in Public Offering to Advance Pain Management Drug - Stock Titan

Click here to get full coverage on Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method - Business Wire

Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method  Business Wire

Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method - Business Wire

Click here to get full coverage on Gerald W. Bruce Appointed President and CEO of Novvae Pharmaceuticals - citybiz

Gerald W. Bruce Appointed President and CEO of Novvae Pharmaceuticals  citybiz

Gerald W. Bruce Appointed President and CEO of Novvae Pharmaceuticals - citybiz

Click here to get full coverage on Virpax Pharmaceuticals announces 1-for-25 reverse stock split - Investing.com

Virpax Pharmaceuticals announces 1-for-25 reverse stock split  Investing.com

Virpax Pharmaceuticals announces 1-for-25 reverse stock split - Investing.com

Click here to get full coverage on Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today? - InvestorPlace

Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today?  InvestorPlace

Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today? - InvestorPlace

Click here to get full coverage on Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc. - Business Wire

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.  Business Wire

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc. - Business Wire

Click here to get full coverage on Virpax Pharmaceuticals Appoints Gerald Bruce as CEO and Dr. Eric Floyd as Chairman - citybiz

Virpax Pharmaceuticals Appoints Gerald Bruce as CEO and Dr. Eric Floyd as Chairman  citybiz

Virpax Pharmaceuticals Appoints Gerald Bruce as CEO and Dr. Eric Floyd as Chairman - citybiz

Click here to get full coverage on Virpax Pharmaceuticals faces Nasdaq delisting over equity shortfall - Investing.com

Virpax Pharmaceuticals faces Nasdaq delisting over equity shortfall  Investing.com

Virpax Pharmaceuticals faces Nasdaq delisting over equity shortfall - Investing.com

Click here to get full coverage on Virpax Pharmaceuticals announces 1-for-10 reverse stock split By Investing.com - Investing.com South Africa

Virpax Pharmaceuticals announces 1-for-10 reverse stock split By Investing.com  Investing.com South Africa

VRPX

Price Chart

Key Statistics

Technicals

About VRPX

Latest News

Virpax Pharmaceuticals to be delisted from Nasdaq - Investing.com

Virpax Pharmaceuticals stock plummets on Nasdaq delisting news - Investing.com

VRPX - Virpax Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

Advanced Charts

Top Gainers

Top Losers